Stay updated on FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Sign up to get notified when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.

Latest updates to the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded detailed Locations sections for multiple sites (California, Illinois, Massachusetts, New York, Rio de Janeiro, São Paulo, Lazio, Liguria, Lombardy, Moscow Oblast, Barcelona). Removed HHS Vulnerability Disclosure link and updated page revision to v3.3.3.SummaryDifference1.0%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedPublications section wording updated to state that publications are automatically filled from PubMed. The page revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check56 days agoChange DetectedThe funding-status notice was removed, but the core trial details (overview, eligibility, and locations) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedThe screenshot shows minor UI and layout adjustments on the Study Details page, with no changes to the study data, eligibility criteria, or listed locations (To avoid being alerted by small changes, set an alert condition by clicking below).SummaryDifference0.3%

- Check99 days agoChange DetectedUpdated page to version v3.2.0, added operating-status notice and a new resource on Spinal muscular atrophy; removed the old revision v3.1.0 reference.SummaryDifference2%

- Check107 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0%

Stay in the know with updates to FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.